{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T20:40:03Z","timestamp":1745786403142,"version":"3.40.4"},"reference-count":10,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2017,10,25]]},"abstract":"<jats:p>The impact of in-utero isotretinoin exposure has been widely reported, with many affected pregnancies failing to reach term.<jats:sup>1 2<\/jats:sup>Due to the low numbers of in-utero isotretinoin exposed pregnancies, the interactions between this drug and rare genetic defects such as microduplication 1q21.1 are unclear, particularly how they might manifest phenotypically. We present this case of in-utero isotretinoin exposure occurring in a child with microduplication 1q21.1. The child was born with congenital abnormalities which did not fit into a single syndrome. Regrettably in-utero exposure to isotretinoin continues to occur. We hope this case will trigger further discussion on the dangers of dispensing Isotretinoin without ensuring stringent pregnancy testing and its potential interaction with genetic abnormalities, in particular with microduplication 1q21.1.<\/jats:p>","DOI":"10.1136\/bcr-2017-219311","type":"journal-article","created":{"date-parts":[[2017,11,4]],"date-time":"2017-11-04T11:05:13Z","timestamp":1509793513000},"page":"bcr-2017-219311","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["The effects of microduplication 1q21.1 and in-utero isotretinoin exposure"],"prefix":"10.1136","volume":"2017","author":[{"given":"Sarah Kirsten","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remy","family":"Toko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,11,4]]},"reference":[{"key":"2025042713012356000_2017.nov04_1.bcr-2017-219311.1","unstructured":"National Organisation for Rare Disorders. Fetal Retinoid Syndrome: National Organization for Rare Diseases Rare Disease Database, 2016. https:\/\/rarediseases.org\/rare-diseases\/fetal-retinoid-syndrome\/ (accessed 21 Nov 2016)."},{"key":"2025042713012356000_2017.nov04_1.bcr-2017-219311.2","unstructured":"Dolan S . Isotretinoin and Pregnancy - A Continued Risk for Birth Defects: Medscape, 2016. http:\/\/www.medscape.com\/viewarticle\/492119 (accessed 21 Nov 2016)."},{"key":"2025042713012356000_2017.nov04_1.bcr-2017-219311.3","unstructured":"Springett A , Morris J . Congenital Anomaly Statistics: 2012: British Isles Network of\u00a0Congenital Anomaly Registers, 2014."},{"key":"2025042713012356000_2017.nov04_1.bcr-2017-219311.4","unstructured":"Genetics Home Reference. 1q21.1 microduplication: U.S. National Library of Medicine, 2014. https:\/\/ghr.nlm.nih.gov\/condition\/1q211-microduplication# (accessed 21 Nov 2016)."},{"key":"2025042713012356000_2017.nov04_1.bcr-2017-219311.5","first-page":"376","article-title":"Retinoids-an overview of clinical applications in dermatology","volume":"2","author":"Archana","year":"2010","journal-title":"Int J Pharm Sci Res"},{"key":"2025042713012356000_2017.nov04_1.bcr-2017-219311.6","unstructured":"British National Formulary. Medicines Complete. London: BMJ Group and Pharmaceutical Press, 2017."},{"key":"2025042713012356000_2017.nov04_1.bcr-2017-219311.7","unstructured":"Schoenwolf G , Bleyl S B , Brauer G , et al . Larsen\u2019s Embryology. London: Churchill Livingstone, 2014."},{"key":"2025042713012356000_2017.nov04_1.bcr-2017-219311.8","doi-asserted-by":"publisher","DOI":"10.1086\/500273"},{"key":"2025042713012356000_2017.nov04_1.bcr-2017-219311.9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/dth.12077","article-title":"Treatment of acne vulgaris in pregnant patients","volume":"26","author":"Pugashetti","year":"2013","journal-title":"Dermatol Ther"},{"key":"2025042713012356000_2017.nov04_1.bcr-2017-219311.10","first-page":"e050108","article-title":"Isotretinoin Embryopathy: Report of One Case","volume":"5","author":"Patraquim","year":"2015","journal-title":"J Pedia Neon Individualized Med"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-219311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T20:01:32Z","timestamp":1745784092000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-219311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,4]]},"references-count":10,"alternative-id":["10.1136\/bcr-2017-219311"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-219311","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2017,11,4]]}}}